Capital Analysts LLC Increases Stock Holdings in Cigna Group $CI

Key Points

• Capital Analysts LLC has increased its stake in Cigna Group (NYSE:CI) by 8.1%, holding 13,378 shares valued at approximately $4.4 million as of the latest SEC filing.
• Cigna Group reported a quarterly EPS of $7.20, beating analysts' expectations, and had a revenue of $67.13 billion, reflecting an 11.0% year-over-year increase.
• The company has declared a quarterly dividend of $1.51 per share, translating to an annualized dividend yield of 2.0% with a payout ratio of 32.97%.

Capital Analysts LLC boosted its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 8.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,378 shares of the health services provider's stock after acquiring an additional 1,007 shares during the quarter. Capital Analysts LLC's holdings in Cigna Group were worth $4,401,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA raised its position in Cigna Group by 0.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider's stock valued at $3,834,493,000 after purchasing an additional 98,715 shares in the last quarter. GQG Partners LLC raised its position in Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock valued at $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Northern Trust Corp raised its position in Cigna Group by 11.7% during the 4th quarter. Northern Trust Corp now owns 3,140,201 shares of the health services provider's stock valued at $867,135,000 after purchasing an additional 328,320 shares in the last quarter. T. Rowe Price Investment Management Inc. bought a new stake in Cigna Group during the 4th quarter valued at $724,517,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Cigna Group by 15.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,495,592 shares of the health services provider's stock valued at $689,133,000 after purchasing an additional 326,633 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Insiders Place Their Bets

In related news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.70% of the stock is currently owned by company insiders.

Cigna Group Stock Up 1.1%

Shares of CI traded up $3.1890 during trading hours on Friday, hitting $304.1390. The company had a trading volume of 1,127,473 shares, compared to its average volume of 2,135,227. The company has a market capitalization of $81.18 billion, a PE ratio of 16.60, a price-to-earnings-growth ratio of 0.88 and a beta of 0.47. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a one year low of $256.89 and a one year high of $370.83. The company's fifty day moving average price is $300.91 and its two-hundred day moving average price is $311.39.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group's payout ratio is 32.97%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CI. Guggenheim reaffirmed a "buy" rating and set a $350.00 target price (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Truist Financial lifted their target price on Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a research report on Monday, May 12th. Piper Sandler lifted their target price on Cigna Group from $348.00 to $374.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Wells Fargo & Company decreased their target price on Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a research report on Thursday, August 14th. Finally, Barclays reduced their price target on Cigna Group from $385.00 to $354.00 and set an "overweight" rating for the company in a research report on Friday, August 1st. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $374.82.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.